Figures & data
Table I. Patient characteristics at baseline (Week 0 unless indicated otherwise).
Figure 1. Twenty-four-hour time-course changes in mean systolic blood pressure (SBP) at baseline (Week 0) and Week 14 according to dipping status in patients with essential hypertension treated with azilsartan or candesartan: (a) non-dipping group; (b) dipping group.
![Figure 1. Twenty-four-hour time-course changes in mean systolic blood pressure (SBP) at baseline (Week 0) and Week 14 according to dipping status in patients with essential hypertension treated with azilsartan or candesartan: (a) non-dipping group; (b) dipping group.](/cms/asset/59afb2ce-00f2-4085-a454-2bcbb9322758/iblo_a_818758_f0001_b.gif)
Figure 2. Changes from baseline (Week 0) to Week 14 in mean systolic blood pressure (SBP) according to dipping status in patients with essential hypertension treated with azilsartan or candesartan: (a) non-dipping group; (b) dipping group.
![Figure 2. Changes from baseline (Week 0) to Week 14 in mean systolic blood pressure (SBP) according to dipping status in patients with essential hypertension treated with azilsartan or candesartan: (a) non-dipping group; (b) dipping group.](/cms/asset/0c4ebecd-6a0c-44d2-b547-17a64fa60d9a/iblo_a_818758_f0002_b.gif)
Table II. Changes in mean systolic blood pressure (SBP, mmHg) from baseline to Week 14 according to baseline dipping pattern in patients with essential hypertension receiving azilsartan or candesartan.
Table III. Changes in mean diastolic blood pressure (DBP, mmHg) from baseline to Week 14 according to baseline dipping pattern in patients with essential hypertension receiving azilsartan or candesartan.